Assurant (AIZ) shares soared 7.5% in the last trading session to close at $193.24. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.9% loss over the past four weeks.
AIZ's shares surged in response to the broader market rally after President Trump announced a 90-day pause of reciprocal tariffs for most countries.
This insurer is expected to post quarterly earnings of $3 per share in its upcoming report, which represents a year-over-year change of -37.2%. Revenues are expected to be $3.05 billion, up 5.7% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Assurant, the consensus EPS estimate for the quarter has been revised 0.6% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on AIZ going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Assurant is a member of the Zacks Insurance - Multi line industry. One other stock in the same industry, Enact Holdings, Inc. (ACT), finished the last trading session 4.6% higher at $33.37. ACT has returned -3.6% over the past month.
Enact Holdings' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.10. Compared to the company's year-ago EPS, this represents a change of +5.8%. Enact Holdings currently boasts a Zacks Rank of #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Assurant, Inc. (AIZ): Free Stock Analysis Report Enact Holdings, Inc. (ACT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
